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Abstract Carboxypeptidase E (CPE) is involved in the 
biosynthesis of peptide hormones and neurotransmitters. To 
determine whether a recently reported Aplysia californica cDNA 
encodes a CPE-like enzyme, this cDNA was expressed in the 
baculovirus system. The Aplysia CPE is optimal at pH 5.5-6.5 
and is inhibited by chelating agents and by the sulfhydryl reagent 
/7-chloromercuriphenyl sulfonate. The effect of divalent cations 
and active site-directed inhibitors on enzyme activity are 
generally similar for Aplysia and rat CPE. Western blot analysis 
using antisera to the N- and C-terminal regions of the Aplysia 
CPE show that the Aplysia CPE is present in atrial glands and 
ovotestis. This Aplysia CPE is purified on a/>-aminobenzoyl-Arg 
Sepharose affinity column under conditions that selectively 
purify rat CPE. Taken together, these results suggest that the 
previously cloned cDNA represents a CPE-like enzyme that is 
expressed in Aplysia tissue. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
In mammals, carboxypeptidase E (CPE; EC3.4.17.10) func-
tions in the processing of peptide hormones and neurotrans-
mitters [1,2]. CPE functions after an endopeptidase has ini-
tially cleaved the peptide precursor at the C-terminal side of a 
basic residue within a particular cleavage site. Following the 
endopeptidase, CPE then removes the Lys or Arg residues 
remaining on the C-terminus of the peptide intermediate. 
CPE was initially found to be associated with enkephalin in 
the bovine adrenal medulla [3] and has been found in numer-
ous peptide-producing tissues [4]. Strong evidence that CPE is 
physiologically involved with peptide biosynthesis comes from 
studies on the CpelzyI'Cpelal mice, which lack functional CPE 
activity due to a point mutation in the coding region of the 
CPE gene [5]. These mice have reduced levels of a variety of 
peptide hormones and neurotransmitters [5-7], supporting the 
proposal that CPE is the major peptide-processing carboxy-
peptidase in mouse neuroendocrine tissues. However, since 
correctly processed pep tides are present in C/>efat/Q>efat mice 
[5-7], it is likely that another carboxypeptidase also is in-
volved in peptide processing. A candidate enzyme, metallocar-
boxypeptidase D (CPD), has been recently identified [8]. 
The amino acid sequence of CPE, deduced from the nucleo-
tide sequence, is highly conserved among human, bovine, rat, 
and mouse, with over 90% amino acid identity among all four 
species [5,9-11]. Anglerfish CPE also shows a high degree of 
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conservation, with approximately 80% amino acid identity 
between the fish sequence and each of the mammalian sequen-
ces [12]. Recently, cDNAs have been obtained for several 
Aplysia metallocarboxypeptidases [13]. Three of these are iso-
forms that differ in only two amino acids near the N-terminus 
of the protein. All three isoforms have highest amino acid 
sequence similarity to CPE, and have been designated CPE-
1, -2, and -3 [13]. However, this similarity with mammalian 
CPE (50% amino acid identity) is not much higher than the 
similarity to other mammalian metallocarboxypeptidases such 
as carboxypeptidase N (41%), and carboxypeptidase M (35%). 
A distinct Aplysia cDNA clone appears to encode a homolog 
of CPD, with approximately 50% amino acid identity among 
the Aplysia clone and rat CPD [13]. 
The purpose of the present study was to investigate whether 
the Aplysia CPE-1 cDNA clone encodes a CPE-like enzyme 
despite the modest amino acid sequence similarity among the 
Aplysia CPE-1 and the mammalian CPEs. Another purpose 
was to examine whether Aplysia contain both CPE- and CPD-
like enzymes. A previous report on a CPE-like enzyme in 
Aplysia [14] used a purification scheme that would isolate 
both CPE and CPD together [8], and so it was not clear 
whether the reported properties reflected one or more en-
zymes. Our finding that Aplysia CPE-1 expressed in baculovi-
rus has properties similar to those of mammalian CPE con-
firms that this Aplysia cDNA encodes a CPE-like enzyme. 
Furthermore, both CPE- and CPD-like enzymes are detected 
in Aplysia tissues, suggesting that despite the modest conser-
vation of amino acids the enzymatic properties have been 
highly conserved through evolution. 
2. Materials and methods 
2.1. Expression of CPE-1 in baculovirus 
The open reading frame of the 561-residue preproCPE-1 (Clone V, 
accession number U37755) was amplified by PCR using sense and 
antisense primers (GIBCO BRL) corresponding to the initiation 
Met and stop codon regions. The sense primer (CAGAATTC4T-
GAGGGATGGATACT) corresponds to nucleotides 96-111, and 
contains an EcoRl site (underlined). The antisense primer (CAGG-
TACCGAGTTACTTGGAC) corresponds to nucleotides 1779-1794, 
and contains a Kpn\ site (underlined). PCR amplification was per-
formed using eLONGase (GIBCO BRL), which contains the proof-
reading enzyme Pyrococcus GB-D polymerase along with Taq poly-
merase. Hot start PCR reactions were performed for 35 cycles, each 
cycle consisting of 94°C for 30 s, 55°C for 30 s, and 68°C for 2 min. 
PCR products were fractionated on 2% NuSieve/1% SeaPlaque agar-
ose (FMC), excised from the gel, and purified using the SpinBind 
DNA method (FMC). After digestion with EcoRl and Kpn\, the 
DNA was subcloned into the EcoRVKpnl sites of the baculovirus 
expression vector pAcSG2 (Pharmingen). Sequence analysis was per-
formed to confirm the identity of the insert. 
The Aplysia CPE cDNA in the baculovirus expression vector (5 u.g) 
was combined with 0.25 (ig of Baculogold viral DNA (Pharmingen) 
and used to transfect 106 Sff cells using the standard calcium phos-
phate procedure recommended by Pharmingen. The Sf9 cells were 
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grown in 4 ml of Sf900-II serum-free media (GIBCO BRL) in a 25 
cm2 flask. Five days after the transfection, the medium was removed 
and a 0.1 ml of aliquot was used to infect another 25 cm2 flask 
containing 106 Sf9 cells in 4 ml of Sf900-II serum-free media. This 
second infection was harvested after 3 days and 1 ml of the medium 
was used to infect 108 cells in 50 ml of media, growing in a 500 ml 
shaker flask. Medium from this third infection was subsequently used 
for large-scale preparation of infected cells. Typically, 10 ml of the 
medium from the third infection was used to infect 2 X 109 cells grow-
ing in 1 1 of Sf900-II media in shaker flasks. Baculovirus expressing 
rat CPE was generated by a similar protocol and has been described 
elsewhere [15]. 
2.2. Purification of CPE and CPD from baculovirus and tissues 
Adult Aplysia californica were purchased from Alacrity Marine Bio-
logical Services (Redondo Beach, CA). Tissues were dissected and 
stored at —70°C until analysis. Tissues were homogenized (Brink-
mann Polytron) in 5-10 vol. of 50 mM NaAc, pH 5.5, containing 
1 M NaCl and 1% Triton X-100. The homogenate was centrifuged 
at 50 000 X g for 20 min at 4°C. The supernatant was loaded onto np-
aminobenzoyl-Arg Sepharose affinity column [8]. The column was 
washed with 20 mM NaAc, pH 5.5, containing 1 M NaCl and 1% 
Triton X-100 followed by 10 mM NaAc, pH 5.5. CPE was eluted with 
50 mM Tris, pH 8.0, containing 50 mM NaCl and 0.01% Triton X-
100. CPD was subsequently eluted with 25 mM arginine in the same 
Tris buffer. CPE was purified from the media of baculovirus-infected 
Sf9 cells using a similar affinity column procedure. For this purifica-
tion, the medium was adjusted to pH 5.5 with NaAc buffer, and then 
applied to a 20 ml p-aminobenzoyl-Arg Sepharose column as de-
scribed above. 
2.3. Enzyme assay 
Carboxypeptidase assays were performed with the substrate dansyl-
Phe-Ala-Arg, as described [16]. Typically, 200 uM substrate and en-
zyme were combined in a final volume of 250 ill of 100 mM NaAc, 
pH 5.5. The reaction mixture was incubated at 37°C for 10 min to 5 h, 
depending on the required sensitivity, and the reaction was terminated 
by the addition of 100 |xl of 0.5 M HC1 followed by 2 ml of chloro-
form. The tubes were mixed, centrifuged at 300 X g for 5 min, and the 
fluorescence in the lower chloroform phase was determined (excita-
tion, 350 nm; emission, 500 nm). To measure the pH optima, the 
reactions were performed in 0.1 M Tris acetate at the indicated pH 
(measured at 37°C). To measure the effect of inhibitors and ions, the 
purified enzyme was pre-incubated with various compounds for 1 h at 
4°C and then assayed as described above. For all measurements the 
assay was performed in duplicate, with variations typically less than 
10%. 
2.4. Antisera generation 
Peptide synthesis and antisera production were performed by Qual-
ity Controlled Biochemicals (Hopkinton, MA). Two peptides were 
synthesized corresponding to the N- and C-terminal regions of Aplysia 
preproCPE-1 [13], The N-terminal peptide (acetyl-CPEVTRIYNL-
SEPSVEKR-amide) corresponds to residues 64-81 and the C-terminal 
peptide (acetyl-CLKELNPDQMREVLERLP-amide) corresponds to 
residues 528-544. Peptides were purified by reverse-phase HPLC, an-
alyzed by mass spectrometry, and conjugated to keyhole limpet he-
mocyanin for immunization of New Zealand white rabbits. Each of 
the two rabbits were immunized with protein conjugates of both N-
and C-terminal peptides. The antiserum to rat CPD was raised against 
the 180 kDa form of purified rat brain CPD [17]. 
2.5. Polyacrylamide gel electrophoresis and Western blot analysis 
Samples were fractionated on a denaturing 10% polyacrylamide gel 
and transferred to nitrocellulose. The blots were probed with a 1:500 
dilution of rabbit polyclonal antisera produced against the peptides 
corresponding to the N- and C-terminal regions of Aplysia CPE, or a 
1:1000 dilution of antiserum directed against CPD. The blots were 
incubated for 1 h with the primary antisera, washed several times with 
Tris buffer saline containing 0.1% Tween-20, and then incubated for 
1 h with a 1:2000 dilution of horseradish peroxidase-conjugated anti-
rabbit IgG. After this incubation, the blot was further washed with 
Tris buffer saline, and the antiserum was detected using the enhanced 
chemiluminescence method (Amersham). 
3. Results 
Upon expression of Aplysia CPE-1 in baculovirus, the 
standard carboxypeptidase assay (at pH 5.5) resulted in 440 
nmol of product per minute per 106 cells, whereas cells in-
fected with a control virus showed only 2 nmol/min per 106 
cells. The amount of carboxypeptidase activity produced with 
the Aplysia CPE-1 construct in baculovirus is comparable to 
the amount of carboxypeptidase activity produced with rat 
CPE, which typically produces 200-500 nmol/min per 106 
cells. To assess whether the Aplysia CPE-1 represents an en-
zyme with properties similar to those of mammalian CPE, the 
baculovirus-expressed protein was purified using a method 
previously developed for the purification of mammalian 
CPE [18]. The Aplysia CPE was purified by this procedure, 
indicating a similarity to mammalian CPE. 
Baculovirus-produced Aplysia CPE-1 has a pH optimum in 
the 5.5-6.5 range, which is slightly different from the more 
acidic pH optimum of rat CPE (Fig. 1). The biggest difference 
in the effect of pH on the Aplysia and rat enzymes is in the 6-
7 range; at pH 6.5, the Aplysia enzyme has approximately 
70% of its maximal activity, but the rat enzyme has only 
20% of the maximal activity. This difference in pH optima 
between the two enzymes was observed in 3^1 separate experi-
ments. 
A variety of inhibitors were used to compare the Aplysia 
and rat enzymes. Both enzymes are substantially inhibited by 
the chelating agents 1,10-phenanthroline and EDTA (Table 
Table 1 
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Fig. 1. Effect of pH on CPE purified from baculovirus-infected Sf9 cell media. Enzyme was assayed with dansyl-Phe-Ala-Arg in Tris acetate 
buffer at the indicated pH, as described in Section 2. Error bars show range of duplicate determinations. 
1). Inhibitors of serine proteases (phenylmethylsulfonyl fluo-
ride) and aspartyl proteases (leupeptin) do not affect either 
Aplysia or rat CPE. Also, some reagents that interact with 
thiol groups (E-64 and iodoacetamide) do not substantially 
inhibit either enzyme. However, a property of CPE that is 
unique among metallocarboxypeptidases is the sensitivity to 
low concentrations of /»-chloromercuriphenyl sulfonate 
(PCMPS). Both the Aplysia and rat enzymes are substantially 
inhibited by 100 uM PCMPS, and are partially inhibited by 
1 uM of this reagent. Neither enzyme is substantially influ-
enced by inhibitors of carboxypeptidase A (benzylsuccinic 
acid), chymotrypsin (tosylphenylalanylchloromethyl ketone) 
or trypsin (tosyllysylchloromethyl ketone). 
Mammalian CPE, like other metalloenzymes, is influenced 
by a variety of divalent cations. Although Aplysia and rat 
CPE are both activated by Co2+ and inhibited by Cd2+, the 
two enzymes differ in the magnitude of the response to the 
cation (Table 2). Ni2+ also differentially affects the two en-
zymes, with no substantial effect on the rat enzyme, and mod-
erate inhibition of the Aplysia enzyme. Both enzymes are sub-
stantially inhibited by 1 mM Cu2+ and 1 uM Hg2+ (Table 2), 
which may reflect their interaction with a thiol group on the 
CPE rather than an interaction in a metal binding site. 
To further explore the similarity between the Aplysia and 
rat enzymes, the inhibitory potency of a variety of active site-
directed compounds was investigated. Of the three active site-
directed inhibitors tested, guanidinoethylmercaptosuccinic 
acid (GEMSA) was the most potent inhibitor of either Aplysia 
or rat CPE (Fig. 2). Another arginine-based inhibitor, 2-mer-
captomethyl-3-guanidinoethylthiopropanoic acid (MGTA) 
also potently inhibits both enzymes. Aminopropylmercapto-
succinic acid (APMSA), which is based on a lysine, is several 
orders of magnitude less potent as a CPE-inhibitor than the 
two arginine-based inhibitors (Fig. 2). This preferred affinity 
for C-terminal arginine residues over C-terminal lysine resi-
dues was confirmed by examining the ability of benzoyl-Gly-
Arg (Hipp-Arg) and benzoyl-Gly-Lys (Hipp-Lys) to inhibit 
the cleavage of dansyl-Phe-Ala-Arg by CPE (Fig. 2). Hipp-
Arg is approximately an order of magnitude more potent than 
the Hipp-Lys. None of the compounds examined showed a 
large difference between rat and Aplysia CPE, suggesting that 
the active site has been conserved. 
Taken together, the properties of the baculovirus-expressed 
Aplysia CPE-1 are more similar to those of rat CPE than to a 
previously reported Aplysia CPE activity [14]. However, this 
previous report used a purification method that does not sep-
arate CPE from CPD. Thus, if Aplysia contain a CPD-like 
enzyme, the previous report would have represented a mixture 
of these two enzymes. To investigate this further, and to see if 
Aplysia express a protein that corresponds to the cDNA clone 
expressed in baculovirus, the purification of CPE was per-
formed with several Aplysia tissues. Both atrial gland and 
ovotestis contain a protein of approximately 70 kDa that 
binds to the p-aminobenzoyl-Arg Sepharose column at pH 
5.5 and elutes when the pH is raised to 8.0. This protein is 
recognized by two separate antisera directed against the N-
and C-terminal regions of the Aplysia CPE cDNA (Fig. 3). 
These antisera also recognize the baculovirus-produced Aply-
sia CPE (lane 2), but not the rat CPE (lane 1, Fig. 3). After 
elution of the affinity columns with the pH 8 buffer, the col-
umns were eluted with Arg in the pH 8 buffer; this has pre-
viously been shown to elute bovine and rat CPD from the 
affinity column [8,17]. The second affinity column eluate con-
tains much less of the 70 kDa protein than the first elute 
Table 2 
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Fig. 2. Effect of active site-directed inhibitors and peptides on CPE activity. The CPE was purified from the media of baculovirus-infected Sf9 
cells, and assayed using dansyl-Phe-Ala-Arg. Solid lines = Aplysia CPE. Dashed lines = rat CPE. O, GEMSA; A, MGTA; D, APMSA; 0 , 
Hipp-Arg; v , Hipp-Lys. 
fraction (Fig. 3). Interestingly, an antiserum to rat CPD rec-
ognizes a protein of 180 kDa in the second eluate of the 
ovotestis, but does not crossreact with baculovirus-produced 
rat or Aplysia CPE (Fig. 3). 
The carboxypeptidase activity in the two affinity column 
eluates were compared with representative inhibitors. The ac-
tivity in the first affinity column eluate is strongly inhibited by 
1 mM CdCl2, as is the baculovirus-expressed Aplysia CPE 
(Table 3). Both the baculovirus-expressed Aplysia CPE and 
the enzyme present in the first affinity column eluate are par-
tially inhibited by 1 mM Hipp-Arg, 10 mM Hipp-Lys, or 
1 \xM PCMPS. The degree of inhibition of the material in 
the first eluate is generally similar to that of the baculovi-
rus-expressed Aplysia CPE and distinct from that in the sec-
ond elute. In contrast, the properties of the material in the 
second affinity column eluate are different from those of the 
baculovirus-produced CPE (Table 3). 
4. Discussion 
The major findings of the present study are that the cDNA 
previously identified as Aplysia CPE-1 encodes an enzyme 
with properties similar to those of mammalian CPE, despite 
modest amino acid sequence similarity. An enzyme with sim-
ilar properties is detected in Aplysia tissues. Specifically, the 
atrial gland and ovotestis contain a protein that co-purifies 
with Aplysia CPE, has the same apparent molecular mass and 
enzyme properties, and is recognized by antisera directed 
against two distinct regions of the protein predicted from 
the cDNA clone. 
The properties of Aplysia CPE-1 and rat CPE are more 
similar to each other than towards other mammalian carboxy-
peptidases that have a similar level of amino acid identity 
[9,13,19,26]. For example, CPE, M, and N all have approx-
imately 45-50% amino acid identity with each other but show 
large differences in their inhibition by the active site-directed 
compounds used in this study. Thus, the overall level of ami-
no acid sequence similarity does not correlate with the appa-
rent conservation of the active site, based on the potencies of 
active site-directed inhibitors. The sensitivity of CPE to low 
concentrations of PCMPS also distinguishes this enzyme from 
CPM and CPN; this property is shared by Aplysia and mam-
malian CPE. Another major difference between mammalian 
CPE and most other known carboxypeptidases is the pH op-
tima; mammalian CPE is maximally active at pH 5-5.5, 
whereas all other metallocarboxypeptidases (except CPD) 
are maximally active at neutral pH. The Aplysia enzyme is 
maximal at pH 6-6.5 (Fig. 1), which is intermediate between 
that of mammalian CPE and the majority of other metallo-
carboxypeptidases. The pH optimum of mammalian CPE cor-
responds to the internal pH of regulated pathway secretory 
vesicles [20,21]. The internal pH of Aplysia secretory vesicles is 
unknown, and it is possible that the pH optimum of the 
Aplysia CPE reflects the internal pH of these vesicles. 
In addition to detecting a CPE-like enzyme in Aplysia tis-
sues, a second CPD-like activity was detected (Table 3). The 
Table 3 
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Fig. 3. Western blot analysis of CPE- and CPD-like enzymes. Protein was purified from the media of baculovirus-infected cells (BV) infected 
with rat or Aplysia (Ap) CPE, from Aplysia atrial gland (At) or ovotestis (Ov), or from rat brain (Br), as indicated. Material present in the 
elute 1 (El) or elute 2 (E2) fractions were fractionated on a denaturing 10% polyacrylamide gel, transferred to nitrocellulose, and probed with 
two separate antisera raised against the N- and C-terminal regions of the Aplysia CPE (Aplysia 1 and 2), or to rat brain CPD, as indicated. 
The positions and sizes of prestained molecular mass markers (BioRad) are indicated. Two exposures of the Aplysia ovotestis E2 probed with 
antiserum to rat CPD are shown (*, longer exposure). 
primary criteria that distinguishes mammalian CPD from 
CPE is the ability of CPD to bind to the Arg-containing 
substrate affinity column at both pH 5.5 and 8.0, whereas 
CPE binds only at pH 5.5 and not at pH 8 [8]. The finding 
that Aplysia tissues contain both CPE and CPD-like enzymes 
is consistent with the recent identification of a partial cDNA 
clone encoding a protein with homology to CPD [13]. CPD-
like cDNAs have been identified in rat [22], duck [23], and 
Drosophila [24], and so it is likely that this protein would also 
be expressed in Aplysia. 
The properties of the Aplysia CPE are generally similar to 
those described in a previous report, even though this pre-
vious characterized material presumably represented a mix-
ture of CPE and CPD-like enzymes due to the purification 
scheme used [14]. The major differences between the Aplysia 
CPE produced in the baculovirus and the previously reported 
activity are the sensitivity to CdCl2 and the relative inhibitory 
potency of Hipp-Arg versus Hipp-Lys. The previous report 
found that 0.1 mM CdCl2 was much less effective as an in-
hibitor of Aplysia CPE than of CPE from mammalian species 
[14]. However, in the present study the baculovirus-expressed 
Aplysia CPE is more sensitive to this ion than the rat CPE 
(Table 2). Also, the previous study found that Hipp-Lys was 
approximately 50-fold less potent at blocking substrate cleav-
age than Hipp-Arg, whereas the present study shows this 
difference to be only 5-10-fold (Fig. 2 and Table 3). Both 
differences could be due to the presence of CPD in the pre-
vious preparation of CPE : the Aplysia CPD is less sensitive to 
both CdCl2 and to Hipp-Lys than CPE (Table 3). In addition 
to CPE and CPD, there are several other known mammalian 
metallocarboxypeptidases, and it is possible that one or more 
of these were also present in the previous preparation. An 
advantage of the present study is the use of cloned cDNAs 
for expression in the baculovirus system. This ensures the 
analysis of a single enzyme since wild type baculovirus does 
not show any significant amount of enzyme activity after pur-
ification on the affinity columns. 
In addition to playing a role in the processing of peptide 
hormones, mammalian CPE has also been proposed to func-
tion in the sorting of prohormones [15]. Recent evidence on 
the interaction of mammalian CPE and proopiomelanocortin 
supports this role for CPE [25]. It is possible that Aplysia CPE 
performs a similar function; the binding of proopiomelano-
cortin to its receptor (presumably CPE) is blocked by thiol 
reagents [25], and both rat and Aplysia CPE are potently 
inhibited by the thiol reagent PCMPS (Table 1). 
Mutations within human CPE may contribute to obesity, as 
recently found in the CpeMlCpeM mouse [5]. Currently, ef-
forts are underway to identify mutations within human CPE, 
and several variants have been found (unpublished data). For 
example, residue 323 of CPE appears as either a Pro or a Leu 
in the human population. Since the Aplysia CPE contains an 
Ala in the corresponding position [13], it is unlikely that the 
Pro versus Leu in human CPE would substantially alter the 
enzymatic properties. In contrast, a variation within a residue 
that is conserved between human and Aplysia CPE would be 
more likely to alter the enzymatic properties. The previously 
published Aplysia CPE sequence, together with the findings 
from the present study that this protein represents a CPE-like 
enzyme, will help evaluate the importance of individual resi-
dues in the overall structure/function relationship of human 
CPE. 
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